These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15465371)

  • 1. The relationship between plasma MMP-1, -7, -8 and -13 levels and embolic potential during carotid endoluminal intervention.
    Bicknell CD; Peck D; Lau NM; Alkhamesi NA; Cowling MG; Clark MW; Jenkins MP; Wolfe JH; Darzi AW; Cheshire NJ
    Eur J Vasc Endovasc Surg; 2004 Nov; 28(5):500-7. PubMed ID: 15465371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity.
    Molloy KJ; Thompson MM; Jones JL; Schwalbe EC; Bell PR; Naylor AR; Loftus IM
    Circulation; 2004 Jul; 110(3):337-43. PubMed ID: 15226217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of matrix metalloproteinases and macrophages to embolization during endoluminal carotid interventions.
    Bicknell CD; Peck D; Alkhamesi NA; Cowling MG; Clark MW; Goldin R; Foale R; Jenkins MP; Wolfe JH; Darzi AW; Cheshire NJ
    J Endovasc Ther; 2004 Aug; 11(4):483-93. PubMed ID: 15298502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome.
    Peeters W; Moll FL; Vink A; van der Spek PJ; de Kleijn DP; de Vries JP; Verheijen JH; Newby AC; Pasterkamp G
    Eur Heart J; 2011 Sep; 32(18):2314-25. PubMed ID: 21289041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid angioplasty in a pulsatile flow model: factors affecting embolic potential.
    Bicknell CD; Cowling MG; Clark MW; Delis KT; Jenkins MP; Hughes AD; Thom SA; Wolfe JH; Cheshire NJ
    Eur J Vasc Endovasc Surg; 2003 Jul; 26(1):22-31. PubMed ID: 12819644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma MMP-9 - a marker of carotid plaque instability.
    Loftus IM; Naylor AR; Bell PR; Thompson MM
    Eur J Vasc Endovasc Surg; 2001 Jan; 21(1):17-21. PubMed ID: 11170872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions.
    Borrelli V; di Marzo L; Sapienza P; Colasanti M; Moroni E; Cavallaro A
    Surgery; 2006 Sep; 140(3):454-63. PubMed ID: 16934609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
    Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
    Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP and TIMP alterations in asymptomatic and symptomatic severe recurrent carotid artery stenosis.
    Sapienza P; Borrelli V; di Marzo L; Cavallaro A
    Eur J Vasc Endovasc Surg; 2009 May; 37(5):525-30. PubMed ID: 19297218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metalloproteinases and their inhibitors are markers of plaque instability.
    Sapienza P; di Marzo L; Borrelli V; Sterpetti AV; Mingoli A; Cresti S; Cavallaro A
    Surgery; 2005 Mar; 137(3):355-63. PubMed ID: 15746792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
    Rautelin HI; Oksanen AM; Veijola LI; Sipponen PI; Tervahartiala TI; Sorsa TA; Lauhio A
    Ann Med; 2009; 41(3):208-15. PubMed ID: 18979291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloproteinase expression in carotid plaque and its correlation with plasma levels before and after carotid endarterectomy.
    Taurino M; Raffa S; Mastroddi M; Visco V; Rizzo L; Torrisi MR; Faraglia V
    Vasc Endovascular Surg; 2007 Dec-2008 Jan; 41(6):516-21. PubMed ID: 18166633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
    Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventional therapy for carotid artery disease using angioplasty and stenting with embolic protection.
    Loftus ML; Schumacher HC; Meyers PM
    Minerva Cardioangiol; 2006 Oct; 54(5):679-85. PubMed ID: 17019402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embolic cerebral ischemia in carotid surgery: a model for human embolic stroke?
    Müller M; Ciccotti P; Axmann C; Kreissler-Haag D
    Med Sci Monit; 2003 Oct; 9(10):CR411-6. PubMed ID: 14523328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.
    Montero I; Orbe J; Varo N; Beloqui O; Monreal JI; Rodríguez JA; Díez J; Libby P; Páramo JA
    J Am Coll Cardiol; 2006 Apr; 47(7):1369-78. PubMed ID: 16580524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention.
    Robertson L; Grip L; Mattsson Hultén L; Hulthe J; Wiklund O
    J Intern Med; 2007 Dec; 262(6):659-67. PubMed ID: 17927738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating matrix metalloproteinase-2 is an independent correlate of proteinuria in patients with chronic kidney disease.
    Nagano M; Fukami K; Yamagishi S; Ueda S; Kaida Y; Matsumoto T; Yoshimura J; Hazama T; Takamiya Y; Kusumoto T; Gohara S; Tanaka H; Adachi H; Okuda S
    Am J Nephrol; 2009; 29(2):109-15. PubMed ID: 18701818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
    Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D
    Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.